Objective: The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) threatened limb classification has been shown to correlate well with risk of major amputation and time to wound healing in heterogeneous diabetic and nondiabetic populations. Major amputation continues to plague the most severe stage 4 WIfI patients, with 1-year amputation rates of 20% to 64%. Our aim was to determine the association between WIfI stage and wound healing and major amputation among patients with diabetic foot ulcers (DFUs) treated in a multidisciplinary setting.
The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system was designed to assist with risk stratification of patients with threatened limbs (and particularly those with diabetes) to allow more meaningful outcome analyses after interventions in what can be a heterogeneous population. 1 Initial reports using this classification system to risk stratify patients have demonstrated good correlation between the WIfI stages and clinical outcomes, including wound healing time and major amputation. [2] [3] [4] [5] [6] In these studies, wound healing time ranged from 95 days in early-stage disease (WIfI stage 1) to 263 days in more advanced disease (WIfI stage 4). 2 Major amputation continues to plague the most severe stage 4 WIfI patients, with 1-year amputation rates ranging between 20% and 64%. [2] [3] [4] More recently, the universality of these correlations has been called into question. In a report of 91 limbs with neuroischemic wounds, Vartanian et al 7 reported similar wound healing and amputation rates for all WIfI classes. Different from prior studies on topic, this one focused on outcomes in patients with neuroischemic wounds. However, 35% of the wounds in the study had an unclassified WIfI stage because of unavailable or uninterpretable hemodynamic measures of ischemia, making it difficult to draw any firm conclusions about the correlation between WIfI stage and clinical outcome in patients with open wounds. The care of foot ulcers is complex and often requires the expertise of a variety of specialists to achieve optimal outcomes. 8 Recently, the use of multidisciplinary limb salvage teams has been shown to improve wound healing and amputation-free survival in patients with lower extremity wounds. 7, [9] [10] [11] However, no studies to date have examined the efficacy of an integrated diabetic foot ulcer (DFU) service and its association with WIfI staging. Therefore, our aim was to determine the association between WIfI stage and wound healing and major amputation among patients with DFUs treated in a multidisciplinary setting.
METHODS
Study cohort. All patients presenting to our multidisciplinary DFU service between July 1, 2012, and December 31, 2015, were enrolled in a prospectively maintained database. Patients were referred by both inpatient and outpatient referrals. Demographics of the patients, comorbidities, glycated hemoglobin proportion (ie, hemoglobin A 1c ), and wound information were recorded at baseline and updated at each subsequent visit. All surgical procedures, including revascularizations (open and endovascular) and wound interventions (wound debridement, coverage, minor amputations, and major amputations), were also recorded and updated in real time. All patients were diabetic and had at least one active lower extremity ulcer at the time of presentation.
The Johns Hopkins Hospital Institutional Review Board approved the study. All patients signed informed consent allowing the collection and maintenance of their demographics and wound data.
WIfI classification. Patients were stratified according to the WIfI classification system on the basis of their initial presentation. All WIfI scores were generated prospectively on the basis of the providers' consensus. Wounds were measured and a WIfI score was assigned at the initial visit and each visit thereafter. The wound measurements and WIfI stages used in this analysis were from the initial visit after debridement, as was intended by the original design of the WIfI classification 1 and in accordance with other WIfI papers in the literature. [2] [3] [4] [5] [6] [7] In brief, the WIfI classification was developed to risk stratify a threatened limb on the basis of a cumulative grading system that assesses wound, ischemia, and infection characteristics. 1 Wound grading is based on the location and severity of an ulcer with or without gangrene. Ischemia grading is based on hemodynamic/perfusion measures (ie, ankle-brachial index or toe pressure). Infection grading is based on the presence and extent of infection. For the purposes of our study, toe pressures were preferentially used, when possible, to classify the ischemia portion of the WIfI stage. In patients with the surgical absence of a toe and noncompressible ankle pressures, pulse volume recordings were employed. For patients with multiple wounds, the WIfI stage was based on the worst first wound. Stage 5 wounds were excluded from analysis because these wounds are considered unsalvageable. 1 For patients with DFU on bilateral limbs, each limb was staged separately. Wounds were considered healed only if epithelialization remained at 30 days after complete healing.
Multidisciplinary diabetic foot service. Our multidisciplinary DFU service is an integrated service that is primarily composed of a vascular surgeon, podiatrist, and endocrinologist as well as a physician assistant, prosthetist, and wound care nurse. Patients are seen by all members of the service at each inpatient admission and weekly outpatient clinic visit in an integrated fashion in a single location and followed up at frequent intervals for ongoing wound assessment and intervention. Consultations from other specialists, including plastic surgery, orthopedic foot and ankle, and infectious disease specialists, are obtained as needed. The service operates on an inpatient and outpatient basis and is designed to optimize wound healing in patients with DFU. Patients are educated about their disease and provided with orthotics, wound care teaching and supplies, and home care when appropriate. The patients' wishes regarding their wound care approach are always considered; however, recommendations are ultimately based on best outcomes practices. Once wound healing is achieved, patients are seen in continued follow-up to allow for early intervention in the case of new ulcer development.
Wound care. In general, wound care was individualized to the wound and the patient; however, certain tenets were adhered to. All devitalized or infected tissue was surgically debrided in the clinic or the operating room. Enzymatic debriders were employed for wounds with fibrinous tissue. Bones with chronic osteomyelitis were typically surgically excised. Once the wound was free from infection and fibrinous tissue, type I collagens or amniotic tissues were placed. In wounds in which osseous and tendinous structures were exposed, either secondary delayed closure or a xenograft or amniotic wound allograft was employed. Once a new dermal layer was generated, continued wound care or split-thickness skin grafting was performed to facilitate wound closure. Finally, wound care also focused on offloading and regulation of edema and moisture by multilayer compression and various foam dressings.
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Statistical analysis. The primary outcomes of our study were wound healing and major amputation. Patients who had these events as of their most recent follow-up visit were censored for the analysis. Wound healing and major amputations were described overall and according to WIfI stage.
All data were summarized as count (%) or mean 6 standard error of the mean as appropriate. Demographic characteristics, comorbidity, and medication information were reported for each patient enrolled in the database. Wound characteristics, interventions, and outcomes were reported for each affected limb.
Baseline and outcome differences between WIfI stages were analyzed using analysis of variance (categorical 
variables) or Student t-tests (continuous variables).
Kaplan-Meier curves, truncated at 1 year, were then constructed to display differences in wound healing and major amputation between the different WIfI stages. Log-rank tests were performed to compare these differences. Patients who healed before they died were counted as healed, and patients who died before they healed were censored. All analyses were performed using Stata version 14.0 (StataCorp, College Station, Tex). A significance level of P < .05 was used for all comparisons.
RESULTS
Study cohort. A total of 217 DFU patients with 437 wounds on 279 limbs were enrolled during the study period, including 28% (n ¼ 61) WIfI stage 1, 11% (n ¼ 24) stage 2, 33% (n ¼ 72) stage 3, and 28% (n ¼ 60) stage 4 (Supplementary Table, online only). Mean age was 58.3 6 0.8 years; 58% of patients were male, and 63% of patients were black.
Patients with stage 4 wounds had a higher prevalence of peripheral arterial disease (PAD; 70% in stage 4 vs 16% in stage 1; P < .001) and were more frequently on dialysis (22% in stage 4 vs 5% in stage 1; P ¼ .05) compared with patients with less advanced (stage 1-3) wounds (Table I) . There was a trend toward a higher prevalence of Medicare or Medicaid insurance for patients with more advanced wounds (80% in stage 4 vs 54% in stage 1; P ¼ .07). The patients' demographics, smoking history, and comorbidities were otherwise similar between groups (P $ .09; Table I ). There were also no significant differences in patients' presenting (baseline) hemoglobin A 1c or nadir hemoglobin A 1c values between groups (P $ .55; Table I ) and depth (stage 1, 0.2 6 0.0 cm; stage 4, 0.8 6 0.1 cm) also increased progressively with increasing wound stage (both, P < .001; Table III ). There was a trend toward increased time from wound onset to first assessment by the multidisciplinary service between groups (stage 1, 2.4 6 0.4 months; stage 4, 2.4 6 0.5 months; P ¼ .12; Table III ).
Interventions. Limbs with stage 4 wounds more frequently underwent ipsilateral revascularization compared with limbs with less advanced staged wounds (55% in stage 4 vs 6% in stage 1; P < .001; Table IV Surgical debridement, attempted wound coverage (ie, skin and skin substitute grafting), and minor amputations were all more common in limbs with more advanced (stage 3-4) disease (all, P < .001; Table IV ).
Primary outcomes. The mean wound healing time for all limbs during the course of the study period was 124 6 7 days, ranging from 90 6 11 days for stage 1 wounds to 190 6 17 for stage 4 wounds (P < .001; Table IV ). WIfI stage was predictive of wound healing, with more advanced disease requiring longer healing times (P < .001; Fig, A) . Wound healing was achieved in 85% 6 2% of patients by 12 months, including 94% 6 2% for stage 1 wounds and 70% 6 5% for stage 4 wounds (P < .001).
Major amputations were required in 5% of limbs overall during the course of the study period (Table IV) . WIfI stage was not significantly associated with major amputation (Fig, B ; P ¼ .99). The incidence of major amputation at 12 months was similar between groups, including 6% of Table IV ). The majority of major amputations (11/13; 85%) were related to progression of infection or inability to clear infection, thus increasing the WIfI stage over time. Fifty percent (two of four) of the stage 4 major amputations were related to failed revascularization in patients with PAD. One of these was a femoral-tibial bypass with polytetrafluoroethylene/distal vein patch in a patient who was noncompliant with anticoagulation therapy. The second was a patient with severe microvascular disease who had a popliteal-dorsalis pedis bypass. The bypass thrombosed because of runoff resistance and was revised to include a distal arteriovenous fistula. At the time of her major amputation, the bypass was open but there was too much tissue loss to salvage the limb.
Subgroup analysis of patients with and without PAD. Because the prevalence of PAD was significantly higher in patients with stage 4 wounds, we performed a subanalysis examining the probability of wound healing and major amputation at 12 months among diabetic patients with and without PAD. The outcomes within these subgroups were the same as those for the full study cohort: WIfI stage was predictive of wound healing, with more advanced disease having lower rates of wound healing by 12 months in both the PAD (stage 1, 93%; stage 4, 69%; P ¼ .003) and non-PAD (stage 1, 95%; stage 4, 72%; P ¼ .02) groups. In contrast, the probability of 12-month major amputation was similar regardless of WIfI stage for both PAD (stage 1, 5%; stage 4, 5%; P ¼ .64) and non-PAD (stage 1, 8%; stage 4, 10%; P ¼ .81) patients.
DISCUSSION
The Society for Vascular Surgery WIfI threatened limb classification has been shown to correlate well with risk of major amputation and time to wound healing in heterogeneous diabetic and nondiabetic populations. [2] [3] [4] [5] [6] In this study, we investigated the association between WIfI stage and wound healing and major amputation among patients with DFUs. Similar to those prior reports, we demonstrate a significant correlation between wound healing and WIfI stage, with stage 4 patients having significantly longer times to wound healing than patients with less advanced disease. However, we also report a low rate of amputation universally, including in advanced WIfI stages with and without PAD, which is somewhat different from previously published data.
In the initial study correlating WIfI classification with major amputation and wound healing, Zhan et al 2 reported 1-year major amputation rates of 0% in WIfI stage 1 and stage 2 patients, 3% in stage 3 patients, and 64% in stage 4 patients. Subsequent reports had somewhat better outcomes but still reported 1-year major amputation rates ranging between 20% and 40% for WIfI stage 4 patients compared with 2% to 10% for stage 1 and stage 2. 3, 4 In our study, the WIfI classification system was not associated with risk of major amputation at 1 year; 6% of both stage 1 and stage 4 patients required major amputation at 1 year. The initial WIfI studies included only patients with critical limb ischemia, which comprises a heterogeneous population of patients including those with ischemic rest pain, patients with nonhealing foot ulcers, and patients with gangrene. [2] [3] [4] [5] Our study was designed to specifically evaluate patients presenting with DFUs, which may partially explain the disparate findings that we report. Subgroup analysis of those patients with PAD demonstrated no differences in major amputation outcomes based on WIfI stage. Thus, the presence of macrovascular disease does not account for the improvement in major amputation rates that we saw at 1 year. It is also possible that our low amputation rate is a reflection of the multidisciplinary DFU service that we established at our institution in 2012. In 2009, Fitzgerald et al 8 published a paper describing the appropriate composition of a diabetic rapid response acute foot team, which included a vascular surgeon and a podiatrist at minimum to address seven essential skills necessary for limb salvage: vascular assessment and revascularization, neurologic workup, appropriate culturing, wound assessment and staging/grading, wound incision and debridement, directed antibiotic therapy, and postoperative monitoring. Subsequently, a number of institutions have developed multidisciplinary limb salvage teams with these skills to treat both diabetic and nondiabetic foot ulcers with good results. 7, [9] [10] [11] Vartanian et al 7 demonstrated that a multidisciplinary limb salvage team, including all-comer evaluation by a podiatrist and a vascular surgeon with inclusion of specialists from infectious disease, plastic surgery, endocrinology, cardiology, and prosthetics/orthotics services as needed, can effectively heal wounds and maintain ambulatory status in patients with limb-threatening neuroischemic wounds. They also reported an overall major amputation rate of 3% (3/91 limbs) during their 1-year study period, 7 which is similar to the 5% 1-year rate observed in our study. Armstrong et al 10 also reported a 46% reduction in below-knee amputations after initiating an integrated interdisciplinary surgical team for the care of DFUs, and Alexandrescu et al 9 reported a 50% reduction in major amputations among diabetic patients after the development of a dedicated multidisciplinary diabetic foot clinic. In our multidisciplinary model, we incorporate visits with a vascular surgeon, podiatrist, endocrinologist, and wound care nurse at every appointment and coordinate with infectious disease, plastic surgery, and orthopedic foot and ankle specialists as needed on a case-by-case basis. Aside from the study by Vartanian et al, 7 the previously published studies reporting WIfI-associated outcomes were based on wound care strategies managed primarily by vascular surgeons with or without podiatric input. [2] [3] [4] [5] [6] Whereas there are no prospective data proving that the use of a multidisciplinary approach to wound care can improve wound healing, we attribute our low amputation rates to this integrated team approach, which is designed to provide expeditious interventions aimed at limb salvage. Surprisingly, there were no significant differences in baseline or nadir hemoglobin A 1c values between WIfI groups in our study. The association between glucose control and WIfI classification has not previously been reported, and these data may serve as a baseline for comparison. Whereas the quantitative impact of having a dedicated endocrinologist assigned as part of the standard multidisciplinary DFU team remains to be determined, our experience with an integrated DFU care model suggests that the input of a multitude of specialties reduces delays in treatment and helps optimize care in a way that a single provider would not be able to achieve.
The favorable outcomes that our study and other studies report come at a cost, and the financial implications of a multidisciplinary approach to foot ulcer care are currently unclear. 12 In the study by Vartanian et al, 7 the median direct cost per hospital admission for treatment by the integrated limb salvage team was $18,873. In contrast, the estimated cost per DFU admission to a general (nonmultidisciplinary) hospital is approximately $9397, depending on wound etiology. 13 That being said, 30-day hospital readmissions have been shown to drop as much as 50% for patients who participate in a limb salvage program, making the argument that perhaps the multidisciplinary care approach for foot ulcer patients can defray the costs associated with this model by improving outcomes in the long term. 7 In addition, approximately 62% of new wounds that developed in patients after their initial presentation were downstaged in our study, which may also result in decreased future costs. The precise overall inpatient and outpatient costs associated with a dedicated DFU team have yet to be delineated and likely need to be weighed against the quality of life years gained by avoiding major amputation in affected patients. In addition to a lack of cost data, the limitations of our study include possible patient selection bias, the fact that not all patients had critical limb ischemia, and the lack of longer term outcomes. First, it is possible that our low amputation rate was a reflection of patient selection bias in that patients with a higher likelihood of limb salvage may have been referred by outside providers for outpatient evaluation to our multidisciplinary service. However, the study group included both outpatient referrals and inpatient consultations. At our institution, our team is responsible for all diabetic foot wounds, including both wound care and amputations. All patients with diabetic foot wounds at our institution were thus included in the study except for a select few who refused to provide consent. As a result, selection bias would be mitigated. Also, the WIfI scoring system was designed to provide an objective (nonbiased) means of risk stratifying patients with threatened limbs, which should minimize the effects of this issue. A second limitation is that our study group included all patients with DFUs. Previous studies evaluating the WIfI classification have centered on those with critical limb ischemia, which may make comparison more difficult. However, the subgroup comparisons in those with and without PAD still showed no differences in outcomes stratified by WIfI stage. Finally, the long-term outcomes among patients with DFUs remain unclear. We report major outcomes at 1 year, which is consistent with prior reports on WIfI-associated outcomes [2] [3] [4] 7 and in concordance with the originally intended purpose of the WIfI classification. 1 However, it is possible that our approach to wound care has simply delayed rather than prevented major amputation. Continued enrollment and observation will assist with our understanding of how diabetes affects wound healing rates over time and whether need for major amputation in advanced-stage wounds can remain persistently low long term with the care of a dedicated multidisciplinary treatment team.
CONCLUSIONS
Among patients with DFUs, the WIfI classification system correlated well with wound healing but was not associated with risk of major amputation at 1 year. Our results suggest that use of a multidisciplinary approach for diabetic foot wound care may help reduce amputation risk among patients with advanced stage 4 disease. Whether these results are a reflection of differences in disease pathophysiologic mechanisms among patients with DFUs compared with all-comers with critical limb ischemia remains to be determined. Future studies investigating outcomes of patients with DFUs treated by a multidisciplinary wound care team, including cost of care and quality of life, are needed to fully describe the efficacy of this endeavor in the long term. 
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